Disorder of fucoglycosan synthesis
MONDO:00177474 clinical trials for this condition and its sub-types, 0 tagged with Disorder of fucoglycosan synthesis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Disorder of fucoglycosan synthesis
-
Dowling-Degos disease 0 trials · 4 incl. sub-types
4 sub-types
- Dowling-Degos disease 1 4 trials
- Dowling-Degos disease 2 0 trials
- Dowling-Degos disease 4 0 trials
- Dowling-degos disease 3 0 trials
-
Peters plus syndrome 0 trials
-
5 sub-types
-
New drug shows promise for controlling rare kidney disorders
Disease control OngoingThis study tests the long-term safety and effectiveness of pegcetacoplan in 100 people with two rare kidney diseases, C3 glomerulopathy and IC-MPGN. Participants previously completed a one-year trial and saw benefit from the drug. The goal is to see if pegcetacoplan can keep redu…
Phase 3 • Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for rare kidney disease patients: early access to pegcetacoplan
Disease control ApprovedThis program provides early access to pegcetacoplan for people aged 12 and older with C3 glomerulopathy or primary IC-MPGN, rare kidney diseases that can lead to kidney failure. Participants must have active disease with significant protein in their urine. The goal is to offer a …
Sponsor: Apellis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC